A Glimpse Into The Expert Outlook On DLocal Through 13 Analysts
13 analysts have expressed a variety of opinions on DLocal (NASDAQ:DLO) over the past quarter, offering a diverse…
Top 3 Financial Stocks That Are Set To Fly This Quarter
The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies. The RSI…
Unveiling 10 Analyst Insights On DLocal
DLocal (NASDAQ:DLO) has been analyzed by 10 analysts in the last three months, revealing a diverse range of…
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday’s session after the company reported first-quarter financial results.…
Why DLocal Stock Is Plunging Wednesday
DLocal shares are trading down Wednesday following weaker-than-expected earnings for the first quarter. The company turned in GAAP EPS of 6 cents, missing analyst estimates for EPS of 12 cents.
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter…
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.…
The Analyst Landscape: 7 Takes On DLocal
Across the recent three months, 7 analysts have shared their insights on DLocal (NASDAQ:DLO), expressing a variety of…
What’s Going On With DLocal Stock Wednesday?
DLocal Ltd (NASDAQ: DLO) shares are trading lower Wednesday after the company reported worse-than-expected financial results and reaffirmed guidance below estimates.
Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance below estimates.